Biodexa Pharmaceuticals PLC has announced a change in its American Depositary Receipts (ADR) ratio, effective July 31, 2025. The new ratio will be one ADR representing 100,000 ordinary shares, up from ...
Biodexa Pharmaceuticals PLC (Nasdaq: BDRX), a clinical stage biopharmaceutical company developing a pipeline of innovative products for the treatment of diseases with unmet medical needs, today ...
Oatly Group AB (NASDAQ:OTLY) tumbled in early trading on Friday after the company announced a plan to implement an ADR ratio change. The company said one ADR representing one ordinary share will ...
But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look. There are plenty of strategies for discovering value stocks, but we have found ...
Zacks Investment Research on MSN
Miniso Group Holding Limited unsponsored ADR (MNSO) declines more than market: Some information for investors
MINISO Group Holding Limited Unsponsored ADR (MNSO) ended the recent trading session at $18.19, demonstrating a -5.99% change from the preceding day's closing price. The stock's performance was behind ...
Zacks Investment Research on MSN
HDLMY vs. ROAD: Which stock is the better value option?
Investors interested in Building Products - Miscellaneous stocks are likely familiar with Heidelberg Materials AG Unsponsored ADR (HDLMY) and Construction Partners (ROAD). But which of these two ...
Biodexa Pharmaceuticals PLC (Nasdaq: BDRX), a clinical-stage biopharmaceutical company developing a pipeline of products aimed at primary and metastatic cancers of the brain, announces a ratio change ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results